ARTICLE
MDMA Lauded as ‘Breakthrough’ Therapy for PTSD Patients
The Food and Drug Administration (FDA) has approved the design of two Phase 3 clinical trials of MDMA for treating PTSD, according to the Multidisciplinary Association for Psychedelic Studies (MAPS), which is funding and leading the clinical trials.
YOU MIGHT ALSO LIKE
CLEAR ALL
